Documents

140210130063 Abdul Falahitawan Tugas 5

Description
m
Categories
Published
of 2
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Related Documents
Share
Transcript
  Computational analysis and predictive modeling of polymorphdescriptors Yungyung Lee 1 , Sourav Jana 1 , Gayathri Acharya 2  and Chi H Lee 2* 1 School of Computing and Endineering, University of Missouri-Kansas City, Missouri, MO 64!, US 2 #ivision of $harmaceutical Sciences, College of $harmacy, University of Missouri-Kansas City, Missouri, MO 64!%, US Keywords:   Binding affinity, QSAR, BCR, o!y or#h, $itoa%ntrone & The computational tools intended for quantitativeassessment of protein-ligand interactions are basedon several factors including protein-ligand docking,molecular dynamis simulation and free energycalculations. To better define the role of bindingaffinity in forming a protein-ligand complex, astructural characterization for putative himan off-targets was recently performed on Nelfinavir, a potent ! -protase inhibitor with pleiotropic effectsin cancer cells. !n this experiment, they have adaptednumerous computational models that integratedmolecular dynamic simulation, free energycalculations with ligand binding site comparison and biological network analysis.There are two integral screening approaches thatcould help identify and characterize the substratesand inhibitors of the efflux proteins and#or transporter system$ the measurement of bindingaffinity and toxicity analysis of substratecompounds. There was a report that drug residenttime and uptake amount are better correlated withdrug efficacy than binding affinity, suggesting thatlead optimization could be efficiently accomplishedwith analyzing the drug uptake profiles. %lthoughnumerous methodologies have been proposed for drug-target screening strategies based on bindingaffinity, there are no efficient computational toolsavailable for the accurate estimation of the druguptake profiles from the point of the molecular structures. !n this study, the uptake rates of &itoaxtrone in the presence of various substratecompounds were examined as an in vitro screeningindex that could help to characterize the binding properties of chemotherapeutic drugs to tumor cellsor efflux proteins.'reast cancer resistant protein (')*+ alsoknown as %')+ or &* or %')/ is a member of transporter super family %T+ binding cassette (%') proteins. ')*+ is known to affect thetherapeutically available concentrations of variousclinical agents. 0ince the ')*+ effluxes a widerange of structurally diverse xenobiotic compoundsfrom cells, the board distribution of ')*+ not onlyrenders less complete distribution of drugs but alsocauses a poor response of cells tochemotherapeutics. ')*+ in con1unction with +-gpexpression at target sites affected the pharmacokinetic profiles of substrates andinhibitors. 0ubsequently, the therapeuticallyavailable concentrations of certain agents increasedin ')*+ knock-out animal models that were highly prone to &itoxantrone induced toxicity.The in vitro studies on the ')*+ efflux systemhave demonstrated that some cell lines displayederratic efflux profiles of doxorubicin and rhodamine2/3, and these observations were attributable to45/ nd  position in the amino acid sequence consistingof arginine, glycine or threonine residues which aresusceptible to numerous posttranslationalmodifications. Three polymorphs, namely 45/* (wild type and two mutants (45/ and 45/T of ')*+, have been identified, and alterations in their expressions and functions were reported 6/27. 8ild-type ')*+ and its variants were markedly expressedin human embryonic kidney (9: cells.The present study was intended to establish therelationships between chemical properties involvedwith the uptake rates of structurally diversesubstrates and ')*+ polymorphs. To achieve thisgoal, we have designed the computational modelconsisting of numerous molecular descriptors. Theuptake rates of &itoxantrone by ')*+ wereexamined in the presence of various pharmacological classes of %') transporter inhibitors, such as anticiral (i.e. 9rythromysin,;oscarnet, antibiotic (i.e. )iprofloxacin,;ebendazole, Novobiocin, <uercitin, calciumchannel blockers (i.e. &itroaxntrone, %cyclovir,;T), +henethyl !T), *aloxifene, *odamin 2/3,0aquinavir, Tamoxifene, antifugal agents (i.e.:etoconazole, horomones (i.e. 9stradiol andimmunosuppressant ()yclosporin. !t washypothesized that any changes in uptake rates of   $an&ano et a!' &itoxantrone are due to competitive binding of these substrates to ')*+.!n the development of computational model prediction of structural specificity of substratecompouns to ')*+, three dimensional structures of substrates were built using %&+%) with raphical=ser !nterface (0emichem, 0hawnee &ission, :0.%&+%) used %ustin &odel 2 (%&2 for thequantum mechanical semi-empirical calculations of interactive energy. )>?900% can generate thenumerical values for molecular descriptors, whereasthe heuristic method (& preselects appropriatemolecular descriptors. The multiple linear <0%*  based on them. The final outcomes were labeled as acharacterization of compounds using derived properties  from %&2 calculations and regressionwith &@*, using descriptors that determinesubstrate specificity to binding receptors is critical todelineate the drug interaction with ')*+ polymorphs and the mechanisms behind the action.The outcomes of study ultimately lead us to discover efficient new drugs with enhanced chemotherapeuticefficacies. The results are the ')*+ mutations may induceconformational changes as manifested by the altereduptake rates of &itoxantrone by ')*+ in the presence of other competitive binding affinity of testsubstrates to each polymorph was affected byvarying descriptors, such as constitutional,topological, geometrical, electrostatic,thermodynamic, and quantum chemical descriptors (ig' 1 ) $ito%antrone u#tae +y the -2 R, -2 G and -2. tran/fected H0 ce!!/ in the #re/ence of variou/ /u+/trateco #ound/'  0o, descriptors involved with the net surfacecharge and energy level of substrates seem to be thecommon integral factors for defining bindingspecificity of selected substrates to ')*+ polymorph. The reproducible outcomes andvalidation process further supported the accuracy of the computational model in assessing the correlationamong descriptors involved with substrate affinity to')*+ polymorph. % quantitative computationapproach will provide important structural insightinto optimal designing of new chemotherapeuticagents with improved pharmacological efficacies.  Acno!edge ent/ %ll the %uthors are kindly thanked for all of  people who supported the authors.. Reference/ ilson &:, Ahou B )alculation of protein-ligand binding affinities. %nnu *ev 'iophys 'iomol 0truct/CCD, 3EB/2-4/ie @, 9vangelidis T, 'ourne +9B ?rug discovery usingchemical systems biologyB weak inhibition of multiplekinases may contribute to the anti-cancer effect of nelfinavir. +@>s )omput 'iol /C22, DBe2CC/C3Dorie :, Tang ;, 'orchard *TB !solation andcharacterization of )aco-/ subclones expressing highlevels of multidrug resistance protein effluxtransporter. +harm *es /CC3, /CB2E2-2E5)opeland *%, +ompliano ?@, &eek T?B ?rug-targetresidence time and its implications for leadoptimization. Nat *ev ?rug ?iscov /CCE, FBD3C-D3G @u , Tonge +HB ?rug-target residence timeB criticalinformation for lead optimization. )urr >pin )hem'iol /C2C, 24B4ED-4D4uo ?, &ulder-krieger T, !1zerman %+, eitman @B;unctional efficacy of adenosine %(/% receptor agonists is positively correlated to thie receptor residence time. 'r H +harmacol /C2/, 2EE(EB254E-25FG
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks